HomeCompareARKZ vs MRK

ARKZ vs MRK: Dividend Comparison 2026

ARKZ yields 100.41% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARKZ wins by $3.90M in total portfolio value
10 years
ARKZ
ARKZ
● Live price
100.41%
Share price
$44.46
Annual div
$44.64
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.96M
Annual income
$1,338,814.61
Full ARKZ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ARKZ vs MRK

📍 ARKZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARKZMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARKZ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARKZ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARKZ
Annual income on $10K today (after 15% tax)
$8,534.94/yr
After 10yr DRIP, annual income (after tax)
$1,137,992.42/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ARKZ beats the other by $1,129,664.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARKZ + MRK for your $10,000?

ARKZ: 50%MRK: 50%
100% MRK50/50100% ARKZ
Portfolio after 10yr
$2.01M
Annual income
$674,306.37/yr
Blended yield
33.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ARKZ
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARKZ buys
0
MRK buys
0
No recent congressional trades found for ARKZ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARKZMRK
Forward yield100.41%2.76%
Annual dividend / share$44.64$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$3.96M$56.8K
Annual income after 10y$1,338,814.61$9,798.13
Total dividends collected$3.54M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ARKZ vs MRK ($10,000, DRIP)

YearARKZ PortfolioARKZ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,741$10,041.11$11,206$366.19+$9.5KARKZ
2$41,657$19,463.90$12,650$502.35+$29.0KARKZ
3$81,107$36,534.31$14,407$694.19+$66.7KARKZ
4$153,264$66,479.78$16,585$967.82+$136.7KARKZ
5$281,398$117,405.38$19,342$1,363.89+$262.1KARKZ
6$502,554$201,457.90$22,913$1,947.19+$479.6KARKZ
7$873,983$336,249.65$27,662$2,823.89+$846.3KARKZ
8$1,481,671$546,509.84$34,159$4,173.35+$1.45MARKZ
9$2,451,279$865,891.08$43,337$6,308.80+$2.41MARKZ
10$3,961,683$1,338,814.61$56,776$9,798.13+$3.90MARKZ

ARKZ vs MRK: Complete Analysis 2026

ARKZStock

ARKZ holds standardized, cash-settled Ether futures traded on the Chicago Mercantile Exchange (CME). With a targeted allocation of over 25% of total assets, the fund operates through a subsidiary structure based in the Cayman Islands. The fund employs a rolling strategy that seeks optimal roll yield by investing in contracts with the most attractive combination of cost, liquidity, and other relevant factors. Typically, these contracts have monthly or quarterly contract periods. Moreover, the fund may invest in front-month Ether Futures contracts and usually rolls to the next nearby contracts at the time believed to generate the greatest roll yield. To provide liquidity and collateral for Ether Futures investments, the remaining assets are diversified into short-term cash instruments, including U.S. Treasury securities and money market instruments. Additionally, the fund may engage in leveraging through reverse repurchase agreements.

Full ARKZ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ARKZ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARKZ vs SCHDARKZ vs JEPIARKZ vs OARKZ vs KOARKZ vs MAINARKZ vs JNJARKZ vs ABBVARKZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.